Cancer Nanotechnology

336 papers and 6.3k indexed citations i.

About

The 336 papers published in Cancer Nanotechnology in the last decades have received a total of 6.3k indexed citations. Papers published in Cancer Nanotechnology usually cover Biomedical Engineering (149 papers), Biomaterials (139 papers) and Molecular Biology (124 papers) specifically the topics of Nanoparticle-Based Drug Delivery (137 papers), Nanoplatforms for cancer theranostics (101 papers) and RNA Interference and Gene Delivery (49 papers). The most active scholars publishing in Cancer Nanotechnology are Kevin M. Prise, Karl T. Butterworth, M. Jannathul Firdhouse, Lalitha Pottail, Inocencio Higuera‐Ciapara, Jesús Bernardino Velázquez-Fernández, Alba Adriana Vallejo‐Cardona, Sawsan M. El-Sonbaty, Farideh Namvar and Andrey V. Solov’yov.

In The Last Decade

Fields of papers published in Cancer Nanotechnology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Cancer Nanotechnology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Cancer Nanotechnology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Cancer Nanotechnology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Cancer Nanotechnology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025